![](https://i.imgur.com/CLvY2jA.png")
The 50 studies included a total of 1,680,003 COVID-19 patients, including those who were hospitalized (67,161 patients from 22 studies), nonhospitalized (4,165 from 5 studies), and any COVID-19 patients, regardless of hospitalization status (1,608,677 from 23 studies).
Worldwide, 49% of COVID-19 survivors reported persistent symptoms 4 months after diagnosis, estimates a meta-analysis of 31 studies published late last week in The Journal of Infectious Diseases.
Regionally, estimated pooled prevalence of lingering COVID-19 symptoms was 51% (95% CI, 37% to 65%) in Asia, 44% (95% CI, 32% to 56%) in Europe, 31% (95% CI, 21% to 43%) in North America, and 31% (95% CI, 22% to 43%) in the United States.
Overall, the meta-analysis showed that a higher percentage of women reported long COVID symptoms than men (49% vs 37%, respectively) and that preexisting asthma was a predisposing factor for lingering symptoms.
"We recommend continued attention be focused on identifying patients at-risk of developing post COVID-19 condition and on quantifying duration of symptoms. With an estimated 200 million individuals affected, post COVID-19 condition's impact on population health and the labor force is enormous," they concluded.
Worldwide, 49% of COVID-19 survivors reported persistent symptoms 4 months after diagnosis, estimates a meta-analysis of 31 studies published late last week in The Journal of Infectious Diseases.
Regionally, estimated pooled prevalence of lingering COVID-19 symptoms was 51% (95% CI, 37% to 65%) in Asia, 44% (95% CI, 32% to 56%) in Europe, 31% (95% CI, 21% to 43%) in North America, and 31% (95% CI, 22% to 43%) in the United States.
Overall, the meta-analysis showed that a higher percentage of women reported long COVID symptoms than men (49% vs 37%, respectively) and that preexisting asthma was a predisposing factor for lingering symptoms.
"We recommend continued attention be focused on identifying patients at-risk of developing post COVID-19 condition and on quantifying duration of symptoms. With an estimated 200 million individuals affected, post COVID-19 condition's impact on population health and the labor force is enormous," they concluded.
